Overview

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

Status:
Terminated
Trial end date:
2021-03-03
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if glutamine can help control and prevent sores, blisters, or inflammation in your mouth or esophagus due to your current treatment. In this study, glutamine will be compared to a placebo. A placebo is not a drug. It looks like the drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
Phase:
Phase 3
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Healios Oncology Nutrition
Treatments:
Everolimus
Sirolimus